Author Archive: Jeremy Parkinson
Market At Record Highs; GDP Growth; Tata Steel And Other Top Cues To Sway The Market Today
Indian share markets continued to surge in the previous session and touched record highs amid gains in international markets and continuous foreign fund inflows. At the closing bell last week, the BSE Sensex closed higher by 184 points and the NSE Nifty finished higher by 54 points. The S&P BSE Mid Cap finished up by […]
The Resurgence Of Small Cap Stocks
Between Q4 16, and Q3 17, the S&P 600 posted an average -1.7% earnings decline, but over the next four quarters earnings are expected to grow by double digits each quarter. The big reason for the increased growth expectations is that small cap stocks are expected to benefit from the tax reform law due to […]
Weekly Forex Forecast For The Week Of Jan. 8
S&P 500 The S&P 500 has rally during the week, as you can see on the weekly chart. We sliced through the 2700 level, breaking a serious amount of resistance, so I think going forward we are going to look at pullbacks as potential buying opportunities, and favor buying on the dips as money managers […]
Global Debt Hits Record $233 Trillion, Up $16Tn In 9 Months
Last June we reported that according to the Institute of International Finance – perhaps best known for its periodic and concerning reports summarizing global leverage statistics – as of the end of 2016, in a period of so-called “coordinated growth”, global debt hit a new all time high of $217 trillion, over 327% of global […]
USDJPY Weekly Analysis – January 7, 2018
USDJPY stayed in a trading range between 110.84 and 114.73 for several weeks. The price action in the range is likely consolidation of the uptrend from 107.31. As long as 110.84 support holds, the upside movement could be expected to resume and another rise to test 115.50 resistance would likely be seen after the consolidation. […]
Celgene To Acquire Impact Biomedicines, Adds Fedratinib To Pipeline
Celgene (CELG) and Impact Biomedicines announced the signing of a definitive agreement in which Celgene will acquire Impact Biomedicines, which is developing fedratinib for myelofibrosis and polycythemia vera. Under the terms of the agreement, Celgene will pay approximately $1.1B upfront and up to $1.25B in contingent payments based on regulatory approval milestones for myelofibrosis. Additional […]
Above The 40 – The S&P 500 Rubberband Stretches Further
AT40 = 67.5% of stocks are trading above their respective 40-day moving averages (DMAs)AT200 = 63.2% of stocks are trading above their respective 200DMAsVIX = 9.2Short-term Trading Call: cautiously bullish Commentary In my last Above the 40 I complained that market breadth was once again suffering thanks to an S&P 500 stretching upward while AT40 […]
Boom Or Bust? How Will Retail Fare In The New Year?
by Knowledge Wharton Wharton’s Barbara Kahn and Columbia’s Mark A. Cohen discuss the U.S. retail outlook for 2018. http://d1c25a6gwz7q5e.cloudfront.net/audio/20180103B-KWR-Kahn-Cohen.mp3 Initial market reports indicate the 2017 holiday season was a lucrative one for American retailers, with sales increasing 5% over the previous year. Online sales were up around 18%, according to early reports, and consumer spending […]
E Cocoa, A Huge Opportunity People Shouldn’t Ignore
Going into 2018 traders are feeling good; U.S markets continue to hit all-time highs; emerging markets have just had their best performing year since 2009; for some reason bitcoin continues to surge and even oil is up for the second year in a row. However, one corner of the trading universe seems to have forgotten that […]
S&P Breaks Out Of Channel
The S&P broke upside from one channel to leave another. This is the third such acceleration in the last six months, leaving the index prone to a parabolic (if not profitable) run. Buying volume was low, but technical strength is good. The Nasdaq rallied just under 1% but hasn’t yet tagged the new upward […]
